Pfizer reaches deal with NICE on Vyndaqel for ATTR-CM
pharmaphorum
MAY 12, 2024
Pfizer reaches deal with NICE on Vyndaqel for ATTR-CM Phil.
Sun.May 12, 2024
116 
Clicks to Conversions – Turning Service Demand to Business Revenue
pharmacy mentor
MAY 12, 2024
As a team deeply committed to the growth and success of pharmacy businesses, we’re thrilled to share the invaluable insights and actionable strategies that our CEO, Saam Ali , presented at The Pharmacy Business Conference. With a mission to empower pharmacy owners and professionals with the knowledge and tools needed to navigate the intricacies of the digital landscape and drive sustainable business growth, we put together this presentation to help professionals boost their marketing strat
Join 11,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
FDA delays decision on Moderna’s RSV vaccine
pharmaphorum
MAY 12, 2024
Moderna’s respiratory syncytial virus (RSV) vaccine has suffered a delay in the US as it chases GSK and Pfizer in the market.
Biocon signs deal with Medix to market generic Saxenda in Mexico
Express Pharma
MAY 12, 2024
Biocon Biopharma announced the signing of a semi-exclusive distribution and supply agreement with Medix, a specialty pharmaceutical company in Mexico, for the commercialisation of its vertically integrated drug product, Liraglutide (gSaxenda), used in the treatment of chronic weight management. Under the terms of this agreement, Biocon will undertake the responsibility of obtaining regulatory approval, manufacturing and supply of the drug product, and Medix will be responsible for its commerci
Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
CVS Health Survey Reports Increases in Mental Health Concerns Since 2020
Pharmacy Times
MAY 12, 2024
The survey reported that approximately 65% of participants were concerned about their mental health, which is a 15% increase since 2020.
Pfizer, AstraZeneca to invest nearly $1 bn in France
Express Pharma
MAY 12, 2024
Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year’s annual ‘Choose France’ business summit. Pfizer said it would invest 500 million euros ($538.5 million) in France to build up its research and development work in the country, while AstraZeneca announced an investment of $388 million for its site at Dunkirk.
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
More Trending
Drop Shipment Efficiency: Navigating Data Challenges in Indirect Partner Transactions
Pharmaceutical Commerce
MAY 12, 2024
This document details the benefits of DataX, a revolutionary solution tailored for pharmaceutical manufacturers. Designed to navigate the complexities of managing serialized data for drop shipments, DataX ensures secure, compliant, and efficient data exchange.
What to look for in a cell culture media supplier: key considerations to reduce risks and manage costs
PharmaTech
MAY 12, 2024
When evaluating a potential vendor, whether for a catalog medium or custom formulation manufacturing, it is important to ensure it can meet your unique needs. This article details five top considerations to carefully evaluate when selecting a cell culture media supplier. Learn how to maximize confidence in your media supply, optimize productivity and help achieve long-term efficiency.
Strategic EPCIS Implementation: Optimizing Supply Chain Management through Strategic EPCIS Implementation
Pharmaceutical Commerce
MAY 12, 2024
This document outlines key strategies and testing protocols critical for optimizing EPCIS implementation, ensuring that pharmaceutical manufacturers can maintain compliance and operational efficiency.
Accelerating cell culture media manufacturing from rapid prototyping through cGMP (May 2024)
PharmaTech
MAY 12, 2024
The importance of successfully scaling up cell culture media cannot be overstated. Not starting the process soon enough can introduce issues with solubility, manufacturability, procurement, and cost management. This article considers technical and commercial best practices that drug developers may enact so that they, their suppliers and media manufacturers, and in turn, their cell culture media remain on the most efficient path to market.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Powder dosed drug patent expirations by year
Drug Patent Watch
MAY 12, 2024
This chart shows the patent expirations for powder dosed drugs over the next decade. The term of drug patents varies.
Successful manufacturing of dry powder media from development to large-scale cGMP production: A two-phase strategy (May 2024)
PharmaTech
MAY 12, 2024
Read about the process utilized and results gained from the use of a two-phase scale-up strategy to manufacture three complex dry powder medium (DPM) formulations. The success of these projects relied on consistently producing acceptable prototype and cGMP material within the customer’s specifications and manufacturing timelines.
New patent expiration for Bayer Healthcare drug ALIQOPA
Drug Patent Watch
MAY 12, 2024
Annual Drug Patent Expirations for ALIQOPA Aliqopa is a drug marketed by Bayer Healthcare and is included in one NDA. It is available from one supplier.
Pfizer CentreOne Perspectives: From Exploring Sterile Injectable Capabilities to Responding to Emerging Trends
PharmaTech
MAY 12, 2024
In this podcast, hear from our global experts Martin Gonzalez, PHD and Katharine Sparhawk as they share exclusive details of Pfizer CentreOne’s sterile injectable capabilities from both a technical expertise and business development point of view. Our experts will explore key topics including emerging sterile injectable trends, the company’s approach to flexibility in capacity planning and emerging trends that are shaping the development of complex biologics like ADCs.
Why Every Small Business Needs an HCM Solution: A Comprehensive Guide
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
New patent for Neurocrine drug ONGENTYS
Drug Patent Watch
MAY 12, 2024
Annual Drug Patent Expirations for ONGENTYS Ongentys is a drug marketed by Neurocrine and is included in one NDA. It is available from two suppliers.
Pfizer CentreOne Perspectives: Sterile Injectable Capabilities and Responding to Emerging Trends
PharmaTech
MAY 12, 2024
Sterile injectables (SI) and complex biologics can be leveraged from both a technical and business development standpoint. Pfizer CentreOne, a CDMO embedded within the Pfizer network, offers services from small scale to large scale for SI and biologic drug substances.
New GERD Medication – Vonoprazan for Erosive Esophagitis
Med Ed 101
MAY 12, 2024
On November 1, 2023, the U.S. Food and Drug Administration (FDA) approved VOQUEZNA® (vonoprazan) as a new treatment for the healing and maintenance of erosive esophagitis and the relief of heartburn associated with erosive esophagitis in adults. This FDA approval marks the first innovation in erosive esophagitis management in nearly 30 years. Erosive Esophagitis Epidemiology […] The post New GERD Medication – Vonoprazan for Erosive Esophagitis appeared first on Med Ed 101.
Episode 921: What if it is not the sedative class that causes delirium – just the depth of sedation?
Pharmacy Joe
MAY 12, 2024
In this episode, I’ll discuss what if it is not the sedative class that causes delirium – just the depth of sedation? Episode 921: What if it is not the sedative class that causes delirium - just the depth of sedation? Subscribe on iTunes , Android , or Stitcher Both the 2013 and 2018 SCCM guidelines for sedation in the ICU recommend avoiding benzodiazepine infusions for sedation in the ICU.
Best Practices to Streamline Compensation Management: A Foundation for Growth
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
STAT+: First recipient of kidney transplant from genetically engineered pig has died, family says
STAT
MAY 12, 2024
Rick Slayman, the first man to receive a kidney transplant from a genetically engineered pig , has died, according to a statement from his family and Massachusetts General Hospital, where he underwent the historic operation in March. “Our family is deeply saddened about the sudden passing of our beloved Rick but take great comfort knowing he inspired so many,” his family said in the statement released Saturday evening.
First recipient of pig kidney transplant dies
pharmaphorum
MAY 12, 2024
The first person to receive a xenotransplant of a kidney from a pig, Rick Slayman, has died almost two months after the procedure
Let's personalize your content